J. Tartaglia

972 citations

21 papers · 742 indexed · h-index 13

Co-authors: Enzo Paoletti William I. Cox Michel Klein Philippe Moingeon Genoveffa Franchini Kent J. Weinhold M L Clements Michael A. Egan
Topics: Poxvirus research and outbreaks (9 papers)Virus-based gene therapy research (8 papers)Immunotherapy and Immune Responses (8 papers)
Cited by: Virology Immunology Epidemiology
Journals: Journal of Virology Annals of the New York Academy of Sciences The Journal of Infectious Diseases
Partner nations: United States France Canada

In The Last Decade

J. Tartaglia

21 papers receiving 712 citations

Peers

Countries citing papers authored by J. Tartaglia

Since Specialization

Citations

This map shows the geographic impact of J. Tartaglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tartaglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tartaglia more than expected).

Fields of papers citing papers by J. Tartaglia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Tartaglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tartaglia. The network helps show where J. Tartaglia may publish in the future.

Co-authorship network of co-authors of J. Tartaglia

This figure shows the co-authorship network connecting the top 25 collaborators of J. Tartaglia. A scholar is included among the top collaborators of J. Tartaglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Tartaglia. J. Tartaglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of predictive markers of HIV disease progression in vaccine trials 2009 ·Vaccine ·Sanjay Gurunathan,Raphaëlle El Habib,Lynn Baglyos,Claude Méric,S. A. Plotkin,Betty Dodet,Lawrence Corey,J. Tartaglia	16
2	OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines 2009 ·Retrovirology ·Bertram L. Jacobs,Karen V. Kibler,Shukmei Wong,Tony L. Huynh,Susan Holechek,Karen L. Denzler,William Arndt,Mark Parrington,J. Tartaglia,Giuseppe Pantaleo	1
3	OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial 2009 ·Retrovirology ·(unknown),Rapee Trichavaroj,Alexandra Schuetz,Weerawan Chuenarom,(unknown),Surat Jongrakthaitae,Silvia Ratto‐Kim,Sorachai Nitayaphan,Len Dally,(unknown),J. Tartaglia,D. P. Francis,(unknown),(unknown),Jae‐Hong Kim	1
4	Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2) 2003 ·Gene Therapy ·(unknown),(unknown),(unknown),Françoise Delisle,(unknown),Patrick Devauchelle,J. Tartaglia,Philippe Moingeon	56
5	Design and In Vivo Immunogenicity of a Polyvalent Vaccine Based on SIVmac Regulatory Genes 2002 ·DNA and Cell Biology ·Zdeněk Hel,Elżbieta Tryniszewska,W P Tsai,Julie Johnson,Robert Harrod,Jake Fullen,V. S. Kalyanaraman,John D. Altman,Jonathan P. McNally,Tatiana Karpova,Barbara K. Felber,J. Tartaglia,Genoveffa Franchini	8
6	Modulation of the antibody response to the HIV envelope subunit by co-administration of infectious or heat-inactivated canarypoxvirus (ALVAC) preparations 2001 ·Vaccine ·Florence Boudet,M. Chevalier,(unknown),J. Tartaglia,(unknown)	10
7	Recombinant viruses as a tool for therapeutic vaccination against human cancers 2000 ·Immunology Letters ·Marie-Claude Bonnet,J. Tartaglia,F. Verdier,Philippe Kourilsky,Alf A. Lindberg,Michel Klein,Philippe Moingeon	73
8	The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity 1998 ·Vaccine ·(unknown),(unknown),(unknown),Michel Chevalier,J. Tartaglia,Lorne Erdile	30
9	Role of the Vaccinia Virus E3L and K3L Gene Products in Rescue of VSV and EMCV from the Effects of IFN-α 1998 ·Journal of Interferon & Cytokine Research ·(unknown),Elizabeth Beattie,Enzo Paoletti,J. Tartaglia,Bertram L. Jacobs	42
10	Multiple Immunizations with Attenuated Poxvirus HIV Type 2 Recombinants and Subunit Boosts Required for Protection of Rhesus Macaques 1996 ·AIDS Research and Human Retroviruses ·(unknown),(unknown),Phillip D. Markham,J. Tartaglia,Enzo Paoletti,Robert C. Gallo,GENOVEFFA FRANCHINI,(unknown)	39
11	Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene 1995 ·The Journal of Infectious Diseases ·Michael A. Egan,(unknown),J. Tartaglia,Enzo Paoletti,Kent J. Weinhold,M L Clements,Robert F. Siliciano	84
12	Highly Attenuated HTLV Type I env Poxvirus Vaccines Induce Protection against a Cell-Associated HTLV Type I Challenge in Rabbits 1995 ·AIDS Research and Human Retroviruses ·Genoveffa Franchini,J. Tartaglia,P. D. Markham,John M. Benson,Jake Fullen,Mark R. Wills,J. Arp,Gregory A. Dekaban,Enzo Paoletti,Robert C. Gallo	42
13	Live Attenuated Vaccinia and Other Poxviruses as Delivery Systems: Public Health Issues 1995 ·Annals of the New York Academy of Sciences ·Marion E. Perkus,Jill Taylor,J. Tartaglia,Steven Pincus,Elizabeth B. Kauffman,John A. Tine,Enzo Paoletti	10
14	Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC. 1995 ·PubMed ·Enzo Paoletti,(unknown),Bernard Meignier,Claude Méric,J. Tartaglia	30
15	Applications of canarypox (ALVAC) vectors in human and veterinary vaccination. 1994 ·PubMed ·Jill Taylor,J. Tartaglia,Michel Rivière,(unknown),B. Languet,G. Chappuis,Enzo Paoletti	23
16	Induction of Cytotoxic T Lymphocytes by Recombinant Canarypox (ALVAC) and Attenuated Vaccinia (NYVAC) Viruses Expressing the HIV-1 Envelope Glycoprotein 1993 ·Virology ·William I. Cox,J. Tartaglia,Enzo Paoletti	73
17	Novel poxvirus strains as research tools and vaccine vectors 1993 ·J. Tartaglia,(unknown),William I. Cox,Jean-Christophe Audonnet,Marion E. Perkus,Antonia Radaelli,Carlo De Giuli Morghen,Bernard Meignier,Michel Rivière,Kent J. Weinhold,Enzo Paoletti	14
18	Specific Activation Strategies for Amplification of Low CTL Signals 1992 ·AIDS Research and Human Retroviruses ·K J Weinhold,J. Tartaglia,Enzo Paoletti,(unknown),David H. Schwartz,M. Juliana McElrath,Nia Roberts,Geoffrey J. Gorse	5
19	Live recombinant viral vaccines. 1990 ·J. Tartaglia,Enzo Paoletti	2
20	Elucidating the structure and function of double-stranded RNA genetic elements associated with biological control of chestnut blight. 1989 ·Europe PMC (PubMed Central) ·Bradley I. Hillman,(unknown),J. Tartaglia,Donald L. Nuss	4

About J. Tartaglia

J. Tartaglia is a scholar working on Virology, Immunology and Genetics, having authored 21 papers that have together received 742 indexed citations. Recurring topics across this work include Poxvirus research and outbreaks (9 papers), Virus-based gene therapy research (8 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Virology (443 citations), Immunology (411 citations) and Epidemiology (273 citations). J. Tartaglia has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Enzo Paoletti, William I. Cox, Michel Klein, Philippe Moingeon, Genoveffa Franchini, Kent J. Weinhold, M L Clements, Michael A. Egan, Robert F. Siliciano and F. Verdier. Their work appears in journals such as Journal of Virology, Annals of the New York Academy of Sciences and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact